Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 (TEMD-2 Study) - Trial NCT06347445
Access comprehensive clinical trial information for NCT06347445 through Pure Global AI's free database. This phase not specified trial is sponsored by Gulhane School of Medicine and is currently Completed. The study focuses on Diabetes Mellitus. Target enrollment is 5707 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Gulhane School of Medicine
Timeline & Enrollment
N/A
Oct 01, 2022
Jan 30, 2023
Primary Outcome
Glycemia control status of Turkish adult patients with diabetes mellitus,Blood pressure control status of Turkish adult patients with diabetes mellitus,Lipid control status of Turkish adult patients with diabetes mellitus.,Weight control status of Turkish adult patients with diabetes mellitus.
Summary
This study evaluates the metabolic control status, cardiovascular risk and frequency of
 comorbidities in diabetic patients followed in tertiary treatment centers in Turkey.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06347445
Non-Device Trial